Cell Cycle Control in Early Drosophila Development
Project Number5R01GM039341-17
Contact PI/Project LeaderORR-WEAVER, TERRY L.
Awardee OrganizationWHITEHEAD INSTITUTE FOR BIOMEDICAL RES
Description
Abstract Text
DESCRIPTION (provided by applicant): In multicellular organisms it is crucial
that cell growth and division be coordinated with developmental events. Recent
advances have defined much of the regulatory circuitry that acts intrinsically
to control transitions through the cell cycle. This makes it possible to build
on this foundation to elucidate how developmental signals affect the cell
cycle, Identification of regulatory genes affecting cell proliferation in
response to developmental cues will have significant implications for
understanding the causes of cancer. Drosophila is an ideal model organism in
which to investigate this important question. The organism modifies its cell-
cycle extensively during development, it is possible to identify mutants with
cell cycle defects, and the genome project permits a rapid transition between
recovering a mutant and isolating the responsible protein. The long-term
objectives are to define the regulation of the meiotic cell cycle during
oogenesis, fertilization, and the early cell cycles of embryogenesis. In
Drosophila the mature oocyte is arrested at metaphase I of meiosis. There is an
activation event, independent of fertilization, as the egg passes through the
uterus that causes the completion of the meiotic divisions. Fertilization is
required for the initiation of embryonic divisions, rapid cycles in which S
phase alternates with mitosis without intervening gap phases. These S-M cycles
of early embryogenesis differ from archetypical mitotic cycles in being
controlled postranscriptionally, being nuclear divisions that occur in a shared
cytoplasm, and as a result requiring localized activation and degradation of
cell cycle regulators. The PAN GU (PNG) protein kinase is required specifically
to promote mitosis and limit DNA replication during the S-M cycles. It is in
complex with the PLUTONIUM (PLU) protein that is essential also to regulate
these cycles. These proteins, together with the product of the giant nuclei
(gnu) gene, are needed to maintain adequate levels of mitotic Cyclin proteins.
The mechanism by which PNG, PLU, and GNU control Cyclin proteins and thus
permit mitosis will be defined. Substrates of the PNG kinase will be
identified, and the regulation of PNG and PLU determined. In vertebrates the
mos oncogene is crucial to maintain metaphase arrest during meiosis in oocytes.
A candidate Drosophila mos gene has been identified; its role during meiosis
will be delineated. Because only a limited number of genes regulating the
meiotic cell cycle, egg activation, and the early S-M embryonic cycles have
been identified, a genetic screen will be carried out to recover additional
control genes for these developmental changes in the cell cycle.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA replicationDrosophilidaeallelescell cyclecell growth regulationcyclinsdevelopmental geneticsearly embryonic stagefertilizationgene expressiongene mutationgenetic mappingguinea pigsimmunoprecipitationin situ hybridizationinvertebrate embryologymeiosismitogen activated protein kinasemolecular cloningnorthern blottingsoogenesispolymerase chain reactionprotein structure functionregulatory genewestern blottingsyeast two hybrid system
No Sub Projects information available for 5R01GM039341-17
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM039341-17
Patents
No Patents information available for 5R01GM039341-17
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM039341-17
Clinical Studies
No Clinical Studies information available for 5R01GM039341-17
News and More
Related News Releases
No news release information available for 5R01GM039341-17
History
No Historical information available for 5R01GM039341-17
Similar Projects
No Similar Projects information available for 5R01GM039341-17